Covance Inc (CVD) financial statements (2021 and earlier)

Company profile

Business Address 210 CARNEGIE CENTER
PRINCETON, NJ 08540
State of Incorp. DE
Fiscal Year End December 31
SIC 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments705648660729593446430
Cash and cash equivalents705536547618483446430
Short-term investments 112114111110  
Receivables331355337332354397344
Inventory, net of allowances, customer advances and progress billings51524948504849
Inventory51524948504849
Prepaid expense and other current assets219211
Income taxes receivable  0 
Deferred tax assets56545352494847
Other undisclosed current assets374396391343351154156
Total current assets:1,5181,5061,4901,5041,3961,3121,236
Noncurrent Assets
Property, plant and equipment862876919914892881871
Intangible assets, net (including goodwill)118119109118110110110
Goodwill118119109110110110110
Intangible assets, net (excluding goodwill)   8   
Other noncurrent assets3538312941  
Prepaid expense and other noncurrent assets3837
Assets held-for-sale, long lived7   
Deferred tax assets, net(13)(13)(31)(32)(21)(21)(20)
Other undisclosed noncurrent assets13133118212120
Total noncurrent assets:1,0151,0331,0591,0531,0421,0291,018
TOTAL ASSETS:2,5322,5392,5492,5572,4382,3412,254
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities210227185238207173142
Accounts payable54835960525342
Employee-related liabilities13012311817114412098
Taxes payable26218812 3
Debt 40  265325325
Other liabilities113112109154104107107
Other undisclosed current liabilities220203237240267242241
Total current liabilities:543581531633843846815
Noncurrent Liabilities
Long-term debt and lease obligation250250250250   
Long-term debt, excluding current maturities250250250250   
Liabilities, other than long-term debt777878148767476
Deferred tax liabilities, net   71   
Other liabilities77787877767476
Other undisclosed noncurrent liabilities131331(39)212120
Total noncurrent liabilities:340342358359979596
Total liabilities:883923889991940941911
Stockholders' equity
Stockholders' equity attributable to parent1,6491,6161,6601,5651,4981,4001,343
Common stock1111111
Treasury stock, value(1,215)(1,214)(1,138)(1,101)(1,096)(1,094)(1,076)
Additional paid in capital959944930860836807782
Accumulated other comprehensive income (loss)(10)38372624(4)(13)
Retained earnings1,9141,8481,8311,7801,7341,6901,649
Total stockholders' equity:1,6491,6161,6601,5651,4981,4001,343
TOTAL LIABILITIES AND EQUITY:2,5322,5392,5492,5572,4382,3412,254

Income statement (P&L) ($ in millions)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
Revenues671687666670647644634
Cost of revenue(583)(615)(599)(608)(40)(52)(586)
Cost of goods and services sold(44)(48)(46)(47)(40)(52)(54)
Gross profit:8872676160759248
Operating expenses(11)(53)(0)(7)  (0)
Other undisclosed operating loss    (544)(541) 
Operating income:77196755635248
Nonoperating income (expense)9(4)(1)(1)(2)(1)14
Investment income, nonoperating14121111
Foreign currency transaction loss, before tax(2)(2)(0)(0)(1)(1)(0)
Interest and debt expense(3)(3)(3)(2)(1)(2)(1)
Other undisclosed income from continuing operations before equity method investments, income taxes3332121
Income from continuing operations before income taxes:86156653615163
Income tax expense (benefit)(20)2(15)(8)(17)(10)(15)
Net income available to common stockholders, diluted:66175146444148

Comprehensive Income ($ in millions)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
Net income:66175146444148
Comprehensive income:66175146444148
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(48)01222810(42)
Comprehensive income, net of tax, attributable to parent:1817624872516

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: